Rohan Mahesh Patil

Rohan Mahesh Patil

Auto-generated profile, based on publicly available information

Rohan Mahesh Patil

Department of Neuroscience, Reproductive and Odontostomatological Sciences, “Federico II” University of Naples, Naples, Italy

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Stroke
Verified
Journal Article
Closed access
ELEster Licastro
Ester Licastro
VVViviana Viscardi
Viviana Viscardi
OCORNELLA CUOMO
ORNELLA CUOMO
RPRohan Mahesh Patil
Rohan Mahesh Patil
Kazuhide HayakawaKazuhide Hayakawa
Kazuhide Hayakawa
Elga EspositoElga Esposito
Elga Esposito
BACKGROUND: Despite promising preclinical results, remote limb ischemic postconditioning efficacy in human stroke treatment remains unclear, with mixed clinical trial outcomes. A potential reason for translational difficulties could be differences in circadian rhythms between nocturnal rodent models and diurnal humans. METHODS: Male C57BL/6J mice were subjected to transient focal cerebral ischemia and then exposed to remote postconditioning during their active or inactive phase and euthanized at 24 hours and 3 days. Infarct volumes were measured using tetrazolium staining. Behavioral outcomes were assessed using the modified Neurological Severity Score, foot-fault test, and adhesive removal test. Brain (striatum ipsilateral) protein levels of PER2 (period circadian regulator 2) and nNOS (neuronal NO synthase) were analyzed by Western blot at 24 hours and 3 days postischemia. 7-nitroindazole, an nNOS inhibitor, was injected intracerebroventricular, and PER2 protein levels were measured during the inactive phase. RESULTS: Remote postconditioning reduced infarct volumes and improved behavioral outcomes in mice when strokes occurred during the inactive phase (Zeitgeber 1–5) but had no effect during the active phase (Zeitgeber 13–17) 24 hours and 3 days postischemia. During the inactive phase, remote postconditioning reduced PER2 expression and increased nNOS levels; however, these changes were not observed during the active phase. Treatment with the nNOS inhibitor abolished the difference in PER2 expression between control and remote postconditioning groups during the inactive phase. CONCLUSIONS: Circadian rhythms influence the neuroprotective effects of remote postconditioning, with greater efficacy observed during the rodent inactive phase up to 3 days. The underlying mechanism may involve nNOS-dependent regulation of PER2 during remote limb ischemic postconditioning. These findings suggest that circadian timing should be considered in remote postconditioning stroke research to improve the translation of neuroprotective strategies from animals to humans.

12 February 2026 in PLOS ONE
Verified
Journal Article
Open access
RPRohan Mahesh Patil
Rohan Mahesh Patil
DBDONG BIN BACK
DONG BIN BACK
GHGen Hamanaka
Gen Hamanaka
RDRakhi Desai
Rakhi Desai
AHAyumi Hayakawa
Ayumi Hayakawa
Elga EspositoElga Esposito
Elga Esposito
Brain meninges contain lymphatic vessels that play roles in clearance of extracellular solute in the central nervous system. But, whether and how the system is involved in acute stroke remains to be fully explored. Here, we show the VEGF-C-Flt4 pathway involvement in brain swelling in acute phase of ischemic stroke in rats. We first confirmed that a prototypical lymphatic mediator VEGF-C was upregulated in brain endothelium and secreted into CSF. Concomitantly, VEGF-C receptor Flt4 was increased in the meninges but not in peri-infarct cortex. Next, we isolated lymphatic endothelial cells from rat meninges using LYVE-1 antibody-conjugated magnetic beads. An in vitro standard matrigel assay confirmed that isolated LYVE1 + cells increased ring-like structures by treatment with VEGF-C or conditioned media from injured brain endothelium subjected to oxygen-glucose deprivation, whereas immunodepletion of VEGF-C from endothelial media decreased the effect. Finally, blocking Flt4 tyrosine kinase in vivo suppressed the acute increase of lymphatic endothelial cells accompanied by reduction of brain swelling. Collectively, the proof-of-concept study suggests that the VEGF-C–Flt4 signaling pathway contributes to brain swelling during the acute phase of ischemic stroke by activating meningeal lymphatic endothelial cells. Targeting this pathway may offer a new approach to mitigate stroke-induced inflammation and edema.

6 May 2026 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Closed access
ELEster Licastro
Ester Licastro
RPRohan Mahesh Patil
Rohan Mahesh Patil
YEYasin Eshraghi
Yasin Eshraghi
AGAlicia Garcia-Culebras
Alicia Garcia-Culebras
Emiri T. MandevilleEmiri T. Mandeville
Emiri T. Mandeville
GPGIUSEPPE PIGNATARO
GIUSEPPE PIGNATARO
In the last three decades, a huge amount of data and number of reports have proved that ischemic brain damage develops differently based on the time of the day at which it occurs. Differences in circadian rhythms between nocturnal rodent models and diurnal humans may explain the lost in translation crisis experienced in the stroke field. To clarify aspects related to circadian rhythm in stroke and to maximize the translatability of preclinical studies in the attempt to identify new promising therapeutic strategies in stroke, changes in biomarkers and systemic biology have been studied after stroke induction in mice. Circadian rhythms influence the metabolic response to stroke in the brain and in the peripheral blood and muscles, with greater efficacy observed during the rodent inactive phase. In the present review article, we intend to summarize the main findings recently published in the field with the attempt to underline the importance of studying the circadian timing in stroke research in order to improve the translation of brain protective strategies from animals to humans.

17 September 2026 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Closed access
RPRohan Mahesh Patil
Rohan Mahesh Patil
SDSusanna Diamanti
Susanna Diamanti
SBSimone Beretta
Simone Beretta
RORaffaele Ornello
Raffaele Ornello
GSGiuliano Sette
Giuliano Sette
GPGIUSEPPE PIGNATARO
GIUSEPPE PIGNATARO
Background: Remote ischemic conditioning (RIC) is a promising neuroprotective strategy for ischemic stroke, but reliable pharmacodynamic biomarkers confirming its biological activity are lacking. Methods: In this translational sub-study of the multicenter randomized phase II TRICS-9 trial, we profiled five circulating microRNAs (miR-181b, miR-150, miR-143, miR-223, and let-7a) in 42 acute stroke patients assigned to RIC or standard medical therapy at 24 h and 72 h post-randomization. Results: At 24 h, miR-143, miR-150, and let-7a were significantly lower in RIC patients, with miR-143 and miR-150 showing strong pharmacodynamic biomarker performance in receiver operating characteristic analysis. At 72 h, miR-181b was significantly elevated in RIC patients, while let-7a and miR-223 remained suppressed. Longitudinal paired analysis revealed significant within-patient temporal increases in miR-181b, miR-150, and miR-143 from 24 to 72 h in RIC patients consistent with a biphasic molecular response to conditioning. Conclusions: These findings identify miR-143, miR-150, let-7a, and miR-181b as candidate pharmacodynamic biomarkers of RIC biological activity. Importantly, none of the candidate miRNAs demonstrated significant correlation with stroke severity, discharge NIHSS, or 90-day functional outcome, consistent with their role as pharmacodynamic rather than prognostic markers. These results provide mechanistic support for translational convergence between preclinical and clinical RIC neuroprotection research and highlight the need for external validation in larger outcome-linked cohorts.